Correlation Between Fulgent Genetics and PACS Group,

Can any of the company-specific risk be diversified away by investing in both Fulgent Genetics and PACS Group, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fulgent Genetics and PACS Group, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fulgent Genetics and PACS Group,, you can compare the effects of market volatilities on Fulgent Genetics and PACS Group, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fulgent Genetics with a short position of PACS Group,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fulgent Genetics and PACS Group,.

Diversification Opportunities for Fulgent Genetics and PACS Group,

0.58

Correlation Coefficient

Fulgent Genetics  PACS Group,

Very weak diversification

The 3 months correlation between Fulgent and PACS is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Fulgent Genetics and PACS Group, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PACS Group, and Fulgent Genetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fulgent Genetics are associated (or correlated) with PACS Group,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PACS Group, has no effect on the direction of Fulgent Genetics i.e., Fulgent Genetics and PACS Group, go up and down completely randomly.

Pair Corralation between Fulgent Genetics and PACS Group,

Given the investment horizon of 90 days Fulgent Genetics is expected to generate 0.56 times more return on investment than PACS Group,. However, Fulgent Genetics is 1.79 times less risky than PACS Group,. It trades about -0.02 of its potential returns per unit of risk. PACS Group, is currently generating about -0.02 per unit of risk. If you would invest  3,032  in Fulgent Genetics on September 13, 2024 and sell it today you would lose (1,010) from holding Fulgent Genetics or give up 33.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	34.34%
Values	Daily Returns

Fulgent Genetics  vs.  PACS Group,

Fulgent Genetics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fulgent Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

PACS Group,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PACS Group, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Fulgent Genetics and PACS Group,

The main advantage of trading using opposite Fulgent Genetics and PACS Group, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fulgent Genetics position performs unexpectedly, PACS Group, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PACS Group, will offset losses from the drop in PACS Group,'s long position.

The idea behind Fulgent Genetics and PACS Group, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.